NAPROXEN
- Product NDC
- 60760-561
- 11-digit product format
- 607600561
- Labeler code
- 60760
- Product ID
- 60760-561_b2d3ba5f-f3ff-3a79-e053-2995a90a50fe
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NAPROXEN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- St. Mary's Medical Park Pharmacy
- Application
- ANDA091416
- Marketing category
- ANDA
- Marketing start
- 2020-10-17
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60760-561-14 | 60760056114 | 14 TABLET in 1 BOTTLE, PLASTIC (60760-561-14) | 14 tablet | 2020-10-17 | 0000-00-00 | No | No | Current |
| 60760-561-15 | 60760056115 | 15 TABLET in 1 BOTTLE, PLASTIC (60760-561-15) | 15 tablet | 2020-10-17 | 0000-00-00 | No | No | Current |
| 60760-561-30 | 60760056130 | 30 TABLET in 1 BOTTLE, PLASTIC (60760-561-30) | 30 tablet | 2020-10-17 | 0000-00-00 | No | No | Current |
| 60760-561-60 | 60760056160 | 60 TABLET in 1 BOTTLE, PLASTIC (60760-561-60) | 60 tablet | 2020-10-17 | 0000-00-00 | No | No | Current |